Enable AccessibilityEnable Accessibility

Director/PDMR Shareholding

February 15, 2016

February 15, 2016 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the “Company”) announces it was notified today that Olivier Bohuon, Non-Executive Director of the Company, acquired 1,000 Ordinary Shares of 5 pence each in the Company (“Shares”) at an average price of £35.5212 per Share. The transaction took place on February 12, 2016, on the London Stock Exchange.

This notification is to satisfy the Company’s obligations under 3.1.4(R)(1)(a) of the Disclosure Rules and Transparency Rules.

Oliver Strawbridge
Senior Assistant Company Secretary

For further information please contact:

Investor Relations


Matthew Osborne

[email protected] +1 781 482 9502

Sarah Elton-Farr

[email protected] +44 1256 894157


Shire enables people with life-altering conditions to lead better lives.

Our strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs.

We focus on providing treatments in Rare Diseases, Neuroscience, Gastrointestinal and Internal Medicine and we are developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas, such as Ophthalmics.